These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 12804416

  • 1. Branched-chain amino acids for hepatic encephalopathy.
    Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C.
    Cochrane Database Syst Rev; 2003; (2):CD001939. PubMed ID: 12804416
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL, Dam G, Les I, Marchesini G, Borre M, Aagaard NK, Vilstrup H.
    Cochrane Database Syst Rev; 2017 May 18; 5(5):CD001939. PubMed ID: 28518283
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nonabsorbable disaccharides for hepatic encephalopathy.
    Als-Nielsen B, Gluud LL, Gluud C.
    Cochrane Database Syst Rev; 2004 May 18; (2):CD003044. PubMed ID: 15106187
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Artificial and bioartificial support systems for liver failure.
    Liu JP, Gluud LL, Als-Nielsen B, Gluud C.
    Cochrane Database Syst Rev; 2004 May 18; 2004(1):CD003628. PubMed ID: 14974025
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Benzodiazepine receptor antagonists for hepatic encephalopathy.
    Als-Nielsen B, Gluud LL, Gluud C.
    Cochrane Database Syst Rev; 2004 May 18; (2):CD002798. PubMed ID: 15106178
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?
    Gluud LL, Dam G, Borre M, Les I, Cordoba J, Marchesini G, Aagaard NK, Vilstrup H.
    Metab Brain Dis; 2013 Jun 18; 28(2):221-5. PubMed ID: 23275147
    [Abstract] [Full Text] [Related]

  • 19. Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy.
    Zhu GQ, Shi KQ, Huang S, Wang LR, Lin YQ, Huang GQ, Chen YP, Braddock M, Zheng MH.
    Aliment Pharmacol Ther; 2015 Apr 18; 41(7):624-35. PubMed ID: 25684317
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.